Company: INVUP
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001193
Chunk: 1254

Company: Investview, Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 1A
Chunk 1254
---
 price that investors are willing to pay in the future
for shares of our common stock. For example:

    ●
    without
    prior stockholder approval, our board of directors has the authority to issue one or more classes of preferred stock with rights
    senior to those of our common stock and to determine the rights, privileges, and preferences of that preferred stock;

    ●
    there
    is no cumulative voting in the election of directors, which would otherwise allow less than a majority of stockholders to elect director
    candidates; and

    ●
    only
    our board of directors or stockholders holding at least 25% of the outstanding capital stock of the Company can call a special meeting
    of stockholders.

Our
indemnification of our directors and officers may limit the rights of our stockholders.

While
our board of directors and officers are generally accountable to our stockholders and us, the liability of our directors and officers
to all parties is limited in certain respects under applicable state law and our articles of incorporation and bylaws, as in effect.
Further, we have agreed or may agree to indemnify our directors and officers against liabilities not attributable to certain limited
circumstances. This limitation of liability and indemnity may limit rights that our stockholders would otherwise have to seek redress
against our directors and officers.

We
may be caused to issue a substantial number of shares of our common stock to our former Chief Executive Officer if our attempts to retire
his note in cash are unsuccessful.

We
owe payment on a promissory note in the principal amount of $1,550,000 to our former Chief Executive Officer, Joseph Cammarata, (the
“Cammarata Note”). Further, the Cammarata Note is convertible into shares of our common stock at $0.008 per share. During
February 2022, we provided 30 days’ notice of our intent to retire and repay the Cammarata Note in cash. Having not timely received
a properly executed conversion notice within the proscribed period, and citing certain other damages incurred by us arising from Mr.
Cammarata’s then ongoing legal proceedings, on or about March 31, 2022, we tendered to Mr. Cammarata cash payment in full for the
Cammarata Note. As of the date of this Report, Mr. Cammarata has not accepted our tender of the cash payment, and instead during 2022
asserted his entitlement to exercise his